US Broker Ratings

Baxter International Inc. (BAX) Stock Analysis: A 30% Potential Upside Sparks Investor Curiosity

Baxter International Inc. (NYSE: BAX), a stalwart in the healthcare sector, is drawing attention from investors with a notable potential upside of 30.30%. With its comprehensive..

DexCom, Inc. (DXCM) Stock Analysis: Robust Growth and a 46.33% Upside Potential for Investors

DexCom, Inc. (NASDAQ: DXCM), a prominent player in the healthcare sector, specifically within the medical devices industry, is renowned for its cutting-edge continuous glucose monitoring (CGM)..

Regencell Bioscience Holdings (RGC): An Investor Outlook on Volatile Price Range and Strategic Focus in TCM

Regencell Bioscience Holdings Limited (RGC), a Hong Kong-based healthcare company, is making waves in the drug manufacturing industry with its focused exploration of Traditional Chinese Medicine..

Summit Therapeutics Inc. (SMMT) Stock Analysis: Exploring a 77% Potential Upside for Investors

Summit Therapeutics Inc. (NASDAQ: SMMT) stands as a compelling player in the biotech sector, capturing investor attention with its unique focus on innovative therapeutic solutions. Renowned..

West Pharmaceutical Services, Inc. (WST): Investor Outlook with a 34% Potential Upside

West Pharmaceutical Services, Inc. (NYSE: WST) is capturing investor attention with a compelling proposition in the healthcare sector, specifically within the medical instruments and supplies industry...

Zimmer Biomet Holdings, Inc. (ZBH) Stock Analysis: Navigating a 15% Potential Upside in the Medical Devices Sector

Zimmer Biomet Holdings, Inc. (NYSE: ZBH), a formidable player in the healthcare sector, has long been a beacon of innovation in the medical devices industry. With..

Sarepta Therapeutics, Inc. (SRPT) Stock Analysis: Evaluating Growth Potential Amid a 13.82% Upside

Sarepta Therapeutics, Inc. (SRPT), a key player in the biotechnology sector, is capturing investor attention with a market capitalization of $1.97 billion. As a commercial-stage biopharmaceutical..

Soleno Therapeutics, Inc. (SLNO) Stock Analysis: A Biotech Play with 136% Potential Upside

Investors seeking transformative opportunities in the biotech sector might find Soleno Therapeutics, Inc. (NASDAQ: SLNO) a compelling candidate. With a market capitalization of $2.65 billion, this..

Stevanato Group S.p.A. (STVN) Stock Analysis: Exploring a 30% Upside in the Healthcare Sector

Stevanato Group S.p.A. (NYSE: STVN), an Italian-based leader in the healthcare sector, is capturing investor attention with its significant growth potential and promising market position. With..

DaVita Inc. (DVA) Investor Outlook: Navigating a 18.88% Potential Upside in the Healthcare Sector

DaVita Inc. (NYSE: DVA), a key player in the healthcare sector, specializes in providing kidney dialysis services across the United States. With a market capitalization of..

Medtronic plc (MDT) Stock Analysis: Exploring the Growth Potential and Analyst Ratings

Medtronic plc (MDT) stands as a formidable giant in the healthcare sector, particularly within the medical devices industry. With a market capitalization of a staggering $123.31..

Bio-Rad Laboratories, Inc. (BIO) Stock Analysis: Navigating a 11.13% Potential Upside in the Medical Devices Sector

Bio-Rad Laboratories, Inc. (NYSE: BIO), a venerable name in the healthcare sector, particularly in medical devices, is drawing investor attention with its substantial market cap of..

Revvity, Inc. (RVTY): Investor Outlook with a 22.58% Potential Upside

Revvity, Inc. (RVTY), a prominent player in the healthcare sector, is capturing investor attention with its robust diagnostics and research offerings. With a market capitalization of..

Exelixis, Inc. (EXEL) Stock Analysis: A Biotech Leader with a Promising 7.11% Upside

Exelixis, Inc. (NASDAQ: EXEL) is a name that resonates significantly within the biotechnology sector, especially for investors seeking opportunities in healthcare innovation. With a market capitalization..

Krystal Biotech, Inc. (KRYS) Stock Analysis: Evaluating Growth Potential with an 8.17% Upside

Krystal Biotech, Inc. (NASDAQ: KRYS) is making waves in the healthcare sector, particularly within the biotechnology industry. With a market capitalization of $5.97 billion, this Pittsburgh-based..

Encompass Health Corporation (EHC) Stock Analysis: Strong Buy Ratings and 23.69% Upside Potential

Encompass Health Corporation (NYSE: EHC), a leader in the healthcare sector, continues to capture investor attention with its robust financial standing and promising growth potential. Specializing..

Neurocrine Biosciences, Inc. (NBIX) Stock Analysis: A Promising Upside with 20.54% Potential for Investors

Neurocrine Biosciences, Inc. (NASDAQ: NBIX) presents an intriguing opportunity for investors seeking exposure to the healthcare sector, specifically within the specialty and generic drug manufacturing industry...

Solventum Corporation (SOLV) Stock Analysis: Uncovering a Potential 11% Upside

Solventum Corporation (SOLV), a prominent player in the healthcare sector, has been capturing the attention of investors due to its diverse operations and promising stock performance...

Medpace Holdings, Inc. (MEDP) Stock Analysis: Navigating Highs with Robust Growth and Cautious Analyst Ratings

Medpace Holdings, Inc. (NASDAQ: MEDP) continues to be an intriguing player in the healthcare sector, specifically within the diagnostics and research industry. As a company offering..

Guardant Health, Inc. (GH) Stock Analysis: A Promising Outlook in Precision Oncology with 38.50% Revenue Growth

Guardant Health, Inc. (NASDAQ: GH), a leader in the precision oncology space, is making waves with its innovative diagnostic solutions, positioning itself as a noteworthy player..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds